Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dr. Martens Plc ( (GB:DOCS) ) just unveiled an update.
Dr. Martens plc has confirmed that, as of 30 January 2026, its issued ordinary share capital stands at 967,319,559 shares, each carrying one voting right, with no shares held in treasury. This updated total voting rights figure provides the formal denominator that investors must use when calculating whether they need to disclose new or changed holdings under UK transparency rules, clarifying the company’s current equity base for shareholders and market participants.
The most recent analyst rating on (GB:DOCS) stock is a Hold with a £72.00 price target. To see the full list of analyst forecasts on Dr. Martens Plc stock, see the GB:DOCS Stock Forecast page.
Spark’s Take on GB:DOCS Stock
According to Spark, TipRanks’ AI Analyst, GB:DOCS is a Neutral.
Dr. Martens Plc’s overall stock score reflects a mix of financial challenges and strategic progress. The most significant factor is the company’s financial performance, which is hindered by declining revenue and profitability. Technical analysis indicates bearish momentum, while valuation suggests the stock is overvalued. Positive corporate events and earnings call insights provide some optimism, but challenges remain.
To see Spark’s full report on GB:DOCS stock, click here.
More about Dr. Martens Plc
Dr. Martens plc is an iconic British footwear company best known for its 1460 boot and other signature “Docs” styles, originally adopted by workers and later by musicians and subcultures worldwide. Headquartered in Northamptonshire and maintaining its heritage ‘Made in England’ production at its original factory, the brand now operates in more than 60 countries with around 3,700 employees, supplying global demand through a mix of Asian manufacturing, direct-to-consumer retail and ecommerce, and wholesale channels. Its product range spans classic boots, shoes, Chelsea boots, loafers, sandals, kids’ footwear, and accessories, all distinguished by hallmark features such as yellow welt stitching and grooved soles; Dr. Martens is listed on the London Stock Exchange and is a constituent of the FTSE 250 index.
Average Trading Volume: 1,235,683
Technical Sentiment Signal: Sell
Current Market Cap: £635M
Find detailed analytics on DOCS stock on TipRanks’ Stock Analysis page.